Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*-Reference-Cited by-同舟云学术

Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*

Published:2011-02-26 Issue:4 Volume:18 Page:302-312
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neuroscience & Therapeutics

Author:

Koliaki Chrysi C.¹,Messini Chaido²,Tsolaki Magda²

Affiliation:

1. Second Department of Internal Medicine‐Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, Haidari, Athens, Greece

2. Third Department of Neurology, Aristotle University of Thessaloniki, General Hospital G. Papanikolaou, Exohi, Thessaloniki, Greece

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1755-5949.2010.00244.x

Reference33 articles.

1. 2009 Alzheimer's disease facts and figures

2. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: A managed care perspective;Rice DP;Am J Manag Care,2001

3. Insight, cognition and quality of life in Alzheimer's disease

4. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia

5. What is the association between depression and Alzheimer’s disease?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-16

2. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features;Cells;2021-01-05

3. Pharmacological treatment of cognitive deficits in nondementing mental health disorders;Dialogues in Clinical Neuroscience;2019-09-30

4. Reversal of neurobehavioral teratogenicity in animal models and human: Three decades of progress;Brain Research Bulletin;2019-08

5. mGlu2/3 receptor antagonists;Advances in Pharmacology;2019